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ABSTRACT Infection with human cytomegalovirus (HCMV) profoundly affects cellular metabolism. Like in tumor cells,
HCMV infection increases glycolysis, and glucose carbon is shifted from the mitochondrial tricarboxylic acid cycle to the
biosynthesis of fatty acids. However, unlike in many tumor cells, where aerobic glycolysis is accompanied by suppression
of mitochondrial oxidative phosphorylation, HCMV induces mitochondrial biogenesis and respiration. Here, we affinity
purified mitochondria and used quantitative mass spectrometry to determine how the mitochondrial proteome changes
upon HCMV infection. We found that the mitochondrial transcription and translation systems are induced early during
the viral replication cycle. Specifically, proteins involved in biogenesis of the mitochondrial ribosome were highly upregu-
lated by HCMV infection. Inhibition of mitochondrial translation with chloramphenicol or knockdown of HCMV-induced
ribosome biogenesis factor MRM3 abolished the HCMV-mediated increase in mitochondrially encoded proteins and sig-
nificantly impaired viral growth under bioenergetically restricting conditions. Our findings demonstrate how HCMV ma-
nipulates mitochondrial biogenesis to support its replication.
IMPORTANCE Human cytomegalovirus (HCMV), a betaherpesvirus, is a leading cause of morbidity and mortality during con-
genital infection and among immunosuppressed individuals. HCMV infection significantly changes cellular metabolism. Akin to
tumor cells, in HCMV-infected cells, glycolysis is increased and glucose carbon is shifted from the tricarboxylic acid cycle to fatty
acid biosynthesis. However, unlike in tumor cells, HCMV induces mitochondrial biogenesis even under aerobic glycolysis. Here,
we have affinity purifiedmitochondria and used quantitative mass spectrometry to determine how the mitochondrial proteome
changes upon HCMV infection. We find that the mitochondrial transcription and translation systems are induced early during
the viral replication cycle. Specifically, proteins involved in biogenesis of the mitochondrial ribosome were highly upregulated
by HCMV infection. Inhibition of mitochondrial translation with chloramphenicol or knockdown of HCMV-induced ribosome
biogenesis factor MRM3 abolished the HCMV-mediated increase in mitochondrially encoded proteins and significantly im-
paired viral growth. Our findings demonstrate howHCMVmanipulates mitochondrial biogenesis to support its replication.
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Human cytomegalovirus (HCMV) is a betaherpesvirus foundin 50% to 90% of human populations worldwide. Infection
of healthy individuals usually involves an asymptomatic acute
phase followed by lifelong carriage in a latent form (1). However,
HCMV is a serious pathogen under conditions of immunoincom-
petence, being a leading cause of morbidity and mortality during
congenital infection, bone marrow or solid organ transplanta-
tions, or AIDS (1). HCMV drives major metabolic reprogram-
ming of host cells during infection (2–5). Akin to tumor cells (6),
HCMV infection leads to an increase in glucose uptake (7) by
upregulation of glucose transporter 4 (Glut4) (8). During infec-
tion, the flux of carbon through glycolysis is increased (2, 3), and
glucose-derived citrate is shuttled from the mitochondria to the
cytosol (cataplerosis) for the biosynthesis of fatty acids, vital for
viral envelopment (9). HCMV also drives an increase in glutamine
conversion to -ketoglutarate to fuel the tricarboxylic acid (TCA)
cycle with carbon (anaplerosis) (10). While in some cancer cells
and in budding yeast the increase in glycolysis under aerobic con-
ditions is associated with suppression of mitochondrial respira-
tion and oxidative phosphorylation (OXPHOS), known as the
“Crabtree effect” (11, 12), HCMV infection is associated with an
increase in both glycolysis (2) and mitochondrial respiration (13).
Mitochondria play a central role in production of cellular energy
and biosynthetic precursors and are key mediators and regulators
of apoptosis and antiviral signaling (14). They contain autono-
mous genomes that are expressed by unique transcription and
translation systems, yet the human mitochondrial genome en-
codes only 13 polypeptides (15). The vast majority of mitochon-
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drial proteins (700 to 1,000 in humans), including all of the pro-
tein components of the mitochondrial transcription and
translation machineries, are encoded by nuclear genes, are trans-
lated in the cytosol, and are imported into mitochondria using
dedicated translocons (15).
HCMV infection is known to profoundly affect mitochon-
dria and their function. Previous studies have indicated that
mitochondrial DNA (mtDNA) synthesis is stimulated by
HCMV infection (16) and that upregulation of OXPHOS genes
occurs late during HCMV lytic cycle at the level of transcrip-
tion (17), translation (18), and protein expression (19). An
increase in endoplasmic reticulum-mitochondrial contact do-
mains by HCMV infection has also been documented (20). While
the HCMV antiapoptotic protein UL37x1 (21) causes fragmenta-
tion of the mitochondrial network (22), this is not associated with
perturbed mitochondrial physiological functions and therefore is
different from other pathological conditions associated with net-
work disassembly (23). On the contrary, HCMV-infected cells are
known to have increased labeling with the membrane potential-
dependent dye tetraphenylphosphonium (TPP) (24) and show
increased oxygen consumption, indicative of induction of respi-
ration (13). Viral UL37x1 may be involved in this process since a
UL37x1 knockout virus was partially impaired in induction of
respiration (13); HCMV 2.7 long noncoding RNA has also been
suggested to affect mitochondrial function by binding respiratory
complex I (25). In this case,2.7 RNA was required to sustain ATP
production throughout viral infection (25).
How HCMV upregulates mitochondrial biogenesis and func-
tion is not well understood. Here, we have used quantitative mass
spectrometry (MS) to measure the changes in the mitochondrial
proteome following HCMV infection in order to understand
these processes. We found that multiple proteins of the mitochon-
drial transcription and translation systems were induced early
during the viral replication cycle. This was accompanied by an
increase in the components of the respiratory chain complexes
encoded by the mitochondrial genome. Proteins involved in mi-
toribosome biogenesis were markedly induced by HCMV infec-
tion. Knockdown of a recently identified member of this group,
MRM3 (26, 27), abrogated virus induction of mitochondrially
encoded proteins and significantly impaired viral growth under
bioenergetically restricting conditions.
RESULTS
Mapping HCMV-induced changes in the mitochondrial pro-
teome using SILAC-MS. To better understand how HCMV stim-
ulates mitochondrial biogenesis and functions, we mapped the
HCMV-induced changes in the abundance of mitochondrial pro-
teins using quantitative mass spectrometry (MS) based on stable
isotope labeling by amino acids in cell culture (SILAC). We car-
ried out a SILAC-based screen in U373 astrocytoma cells, which in
our previous studies appear to be more sensitive to changes in
mitochondrial function mediated by HCMV than fibroblasts (25)
and gave higher yields and purity of mitochondria (unpublished
results). Three parallel cultures of U373 cells were differentially
labeled with SILAC media (containing “light,” “heavy,” or “me-
dium” amino acids) and then infected with the HCMV Merlin
strain for 48 or 60 h or mock infected (see Fig. S1 in the supple-
mental material). Following infection, the three populations of
cells were combined and mitochondria were isolated from the
pooled-cell mixture by affinity purification. Lysed mitochondria
were digested into peptides followed by MS. We identified 1,171
cellular proteins with at least 2 unique peptides in our mitochon-
drial preparation (see Table S1A in the supplemental material).
According to Gene Ontology (GO) annotation, 47% of identified
proteins were mitochondrial, while 17% and 12% were annotated
to the closely associated organelles the endoplasmic reticulum
(ER) and the nucleus, respectively (Fig. 1A). At 48 h postinfection
(hpi), over 20% of identified proteins exhibited a specific and
significant change using a 2-fold cutoff (Fig. 1B). Virus-induced
changes to mitochondrial proteins persisted up to 60 hpi (see
Fig. S2A in the supplemental material) and were reproducible (see
Fig. S2B and Table S1B).
HCMV reduces the association of mitochondria with pro-
teins of other cellular structures and downregulates antiviral
proteins. To find functional groups within the proteins whose
abundance was significantly changed by HCMV infection, we
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FIG 1 SILAC-MS analysis of the changes in the mitochondrial proteome
following HCMV infection. (A) Subcellular localization annotation of 1,171
human proteins identified in isolated mitochondria with at least 2 unique
peptides represented as a percentage of the total. Gene Ontology (GO) infor-
mation was imported using the UniProt database. (B) Scatter plot representing
fold change in “heavy” (mock)/“light” (HCMV 48 hpi) protein abundance in
isolated mitochondria. A total of 12.3% (144) of proteins were increased over
2-fold following HCMV infection (red), 8.6% (101) were downregulated
(blue), and 79.1% (926) were not significantly changed (gray).
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used the Database for Annotation, Visualization and Integrated
Discovery (DAVID) (28). GO biological processes enriched
within downregulated proteins included the categories “Cell ad-
hesion,” “Actin cytoskeleton organization,” “Glycolysis,” and
“Response to virus” (see Table S2A in the supplemental material).
Reduction in actin binding proteins is consistent with HCMV
disruption of the actin cytoskeleton (29–31). Given the docu-
mented activation of glycolysis by HCMV (2, 3), the observed
reduction in glycolytic enzymes may appear counterintuitive.
However, we found that glycolytic enzymes were not downregu-
lated during infection in total cell extracts (our unpublished data);
rather, the association of these enzymes with mitochondria was
reduced in infected cells. Glycolytic enzymes are associated with
mitochondria in mammalian cells (32). In plant cells (33, 34), the
association of glycolytic enzymes with mitochondria is dynami-
cally changed in response to respiratory demand (35). Whether
HCMV-induced disassociation of glycolytic proteins from mito-
chondria has a metabolic role in HCMV replication remains to be
determined. Of note, nonmitochondrial proteins were less associ-
ated with mitochondria upon infection, likely due to virus-
induced fragmentation of the mitochondrial network (22).
In U373 cells, we observed a downregulation of several antivi-
ral proteins (see Table S2A in the supplemental material). Most
significant was an 8.3-fold reduction in the proapoptotic and
proautophagic protein BCL-2/adenovirus E1B interacting protein
3 (BNIP3). We also observed viral induction of acetyl-coenzyme A
acyltransferase 2 (ACAA2), which was shown to mitigate apopto-
sis induced by BNIP3 (36). A reduction of the antiviral signaling
proteins MAVS and STING, which act in interferon beta (IFN-)
induction through the IFN regulatory factor 3 (IRF3) pathway,
was also seen. This reduction is in line with HCMV-induced
downregulation of IRF3 (19) and inhibition of IFN- induction
(37). A reduction in STING has also previously been observed in
total cell extracts of HCMV-infected fibroblasts (19), although no
changes in total amounts or subcellular localization of MAVS
were observed (19, 38). MAVS may therefore undergo different
fates in HCMV-infected fibroblasts and U373 cells. Our data point
to a reduction in two additional viral restriction factors implicated
in the interferon response: gamma-interferon-inducible protein
16 (IFI16) and phospholipid scramblase 1. IFI16 is required for
activation of the IRF3 signaling cascade during human herpes
simplex virus 1 (HSV1) infection (39). IFI16 was also shown to
restrict HCMV replication, yet its inhibitory activity was not de-
pendent on IFN- induction (40). Phospholipid scramblase 1, a
restriction factor of hepatitis B virus (41), was shown to augment
the IFN response by increasing the expression of potent antiviral
genes (42).
Cellular pathways induced by HCMV infection. DAVID
analysis of HCMV-upregulated proteins showed enrichment of
several cellular pathways, which included the KEGG_PATHWAY
categories “Arginine and proline metabolism,” “Fatty acid metab-
olism,” and “One carbon pool by folate” (see Table S2B in the
supplemental material).
Within arginine metabolism-related proteins, the highest in-
duction (8.7-fold) was found in arginase II (ARG2). L-Arginine is
the source for the synthesis of nitric oxide (NO), which plays a
major role in host defense against microbial infection. In mouse
macrophages, induction of arginase II was shown to prevent NO
production by depleting intracellular arginine pools (43). Induc-
tion of arginase II was also previously detected during herpes sim-
plex virus 1 (HSV-1) infection of cornea (44). Consequently, it
may be that arginase II induction aids herpesviruses to suppress a
host NO antiviral response.
Fatty acid synthesis is induced by HCMV infection (9). In par-
ticular, very-long-chain fatty acids are important for the produc-
tion for infectious virions (45). HCMV-induced lipogenesis re-
quires the inhibition of beta oxidation of long-chain fatty acids
and is mediated by recruitment of the cellular protein viperin to
mitochondria (46, 47). Interestingly, we found that proteins in-
volved in beta oxidation of short and medium fatty acids were
induced by HCMV (see Table S2B in the supplemental material).
These included the mitochondrial short-chain-specific acyl coen-
zyme A (acyl-CoA) dehydrogenase (SCAD [2.3-fold induction])
and medium-chain-specific acyl-CoA dehydrogenase (MCAD
[4.4-fold induction]), which catalyze the first step of oxidation of
these fatty acids. It also included mitochondrial acetyl-coenzyme
A acyltransferase 2 (ACAA2 [3-fold induction]), which catalyzes
the last step of oxidation. In contrast, we found that the carnitine/
acylcarnitine carrier protein, required for transport of long fatty
acids into mitochondria, as well as the very-long-chain fatty acid-
specific acyl-CoA dehydrogenase and trifunctional protein (TFP)
complex, which catalyze beta oxidation of long-chain fatty acids,
were not significantly changed by HCMV infection; this is consis-
tent with the documented suppression of this pathway by HCMV
(47). Whether a specific increase in the oxidation of short-chain
fatty acids is supportive of HCMV replication remains to be de-
termined. The induction of one-carbon metabolism in mitochon-
dria is discussed below.
Mitochondria fromHCMV-infectedcellswere enrichedwith
proteins containing predicted N-terminal mitochondrial tar-
geting sequences. By inspection of our list of mitochondrial pro-
teins upregulated by infection, it appeared that mitochondrial
matrix proteins are much more increased than proteins of the
other mitochondrial subcompartments. As most matrix proteins
contain N-terminal mitochondrial targeting peptides (mTP), we
expected an enrichment of proteins displaying a high probability
of containing an mTP in our data set. We identified mTP scores
for all of our quantified proteins using the TargetP 1.1 server (48).
We then plotted the TargetP score against the log heavy/light
amino acid ratio (H/L ratio) (see Fig. S3A in the supplemental
material). Proteins with a negative log ratio were relatively en-
riched in infected cells, which were labeled with light amino acids.
We performed this analysis on data searched against the whole
UniProt database (see Fig. S3Aa) and against the UniProt database
of mitochondrial proteins only (annotated by Mitocarta [49]) (see
Fig. S3Ab). In both cases, the averaged log (ratio) for high TargetP
scores was significantly lower than the averaged log (ratio) for low
scores, suggesting that proteins with high score of predicted mTP
are indeed selectively enriched in HCMV-infected cells. Our find-
ings may suggest that proteins containing an mTP are preferen-
tially imported into mitochondria in infected cells. The reported
increased accumulation of TPP in HCMV-infected cells (24) may
indicate an increase in the mitochondrial membrane potential in
infected cells, which is the driving force for import through the
TIM complex into the matrix.
HCMV specifically upregulated proteins involved in expres-
sion of themitochondrial genome.Thirty-three of the 144 (23%)
proteins upregulated by HCMV function in expression and main-
tenance of the mitochondrial genome (Table 1). This group com-
prised ~40% of virally upregulated proteins annotated “mito-
HCMV Induces Mitochondrial Translation
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TABLE 1 Fold change and suggested functions of mitochondrial expression factors upregulated by HCMV infection
Protein Gene(s)
H/L ratio
(mock/48 hpi)
No. of unique
peptides Suggested mitochondrial function(s) Reference(s)
mTERF domain-containing
protein 1, mitochondrial
MREF3, MTERFD1 0.16 3 Mitochondrial ribosome biogenesis
(mouse)
50
Mpv17-like protein 2 MPV17L2 0.19 2 Mitochondrial ribosome assembly
(human)
51
Polymerase delta-interacting
protein 2
POLDIP2 0.22 6 Mitochondrial nucleoid associated
(human)
100
Putative methyltransferase
NSUN4
NSUN4 0.25 3 Mitochondrial ribosome assembly
(human, mouse)
52
28S ribosomal protein S27,
mitochondrial
MRPS27 0.23 5 Small mitochondrial ribosome
subunit (bovine)
101
GTPase Era, mitochondrial ERAL1 0.25 7 Mitochondrial ribosome biogenesis
(human)
53, 54
39S ribosomal protein L38,
mitochondrial
MRPL38 0.26 7 Large mitochondrial ribosome
subunit (bovine)
102
39S ribosomal protein L37,
mitochondrial
MRPL37 0.27 8 Large mitochondrial ribosome
subunit (bovine)
102
Dimethyladenosine transferase
2, mitochondrial
TFB2M 0.28 5 Mitochondrial transcription
activation (mouse, human)
103
28S ribosomal protein S9,
mitochondrial
MRPS9 0.28 12 Small mitochondrial ribosome
subunit (bovine)
101
28S ribosomal protein S31,
mitochondrial
MRPS31 0.30 4 Small mitochondrial ribosome
subunit (bovine)
101
RNA methyltransferase-like
protein 1
MRM3, RNMTL1 0.30 2 rRNA methyl transferase,
mitochondrial ribosome biogenesis
(mouse)
26, 27
GTP-binding protein 5 GTPBP5 0.31 3 Large mitochondrial ribosome
associated, mitochondrial
translation regulation (human)
104
Dimethyladenosine transferase
1, mitochondrial
TFB1M 0.34 4 Mitochondrial transcription (human) 103
ATP-dependent RNA helicase
SUPV3L1, mitochondrial
SUPV3L1 0.35 9 DNA/RNA helicase, mitochondrial
RNA turnover and processing
(human)
105
Mitochondrial tRNA-specific
2-thiouridylase 1
TRMU 0.35 4 Mitochondrial translation regulation
(human)
106
Probable asparagine-tRNA
ligase, mitochondrial
NARS2 0.37 2 tRNA synthetase (human) 107
Mitochondrial ribonuclease P
protein 1
TRMT10C, MRPP1 0.38 12 Mitochondrial tRNA maturation
(human)
108
G-rich sequence factor 1 GRSF1 0.39 10 Mitochondrial mRNA turnover,
mitochondrial ribosome biogenesis
(human)
109
Putative ATP-dependent RNA
helicase DHX30
DHX30 0.40 23 Mitochondrial translation regulation
(human)
110
Tyrosine—tRNA ligase,
mitochondrial
YARS2 0.42 6 Mitochondrial tRNA synthetase
(human)
111
Methionyl-tRNA
formyltransferase,
mitochondrial
MTFMT 0.44 2 Mitochondrial translation (human) 112
28S ribosomal protein S29,
mitochondrial
DAP3 0.44 11 Small mitochondrial ribosome
subunit (bovine)
101
tRNA modification GTPase
GTPBP3, mitochondrial
GTPBP3 0.44 4 Mitochondrial translation regulation
(human)
113
SRA stem-loop-interacting
RNA-binding protein,
mitochondrial
SLIRP 0.45 3 Mitochondrial mRNA turnover
(human)
114
Glycine—tRNA ligase GARS 0.46 6 Mitochondrial tRNA synthetase
(human)
115
28S ribosomal protein S22,
mitochondrial
MRPS22 0.46 9 Small mitochondrial ribosome
subunit (bovine)
101
(Continued on following page)
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chondrial” by GO, emphasizing the enrichment of this functional
group among mitochondrial proteins upregulated by infection.
This group included proteins associated with the mitochondrial
nucleoid, proteins involved in mitochondrial mRNA transcrip-
tion and turnover, mitochondrial tRNA maturation enzymes, mi-
tochondrial tRNA synthetases, components of the small and large
subunits of the mitoribosome, and proteins involved in mitoribo-
some assembly (Table 1). We have confirmed that the measured
upregulation of mitochondrial expression proteins was not signif-
icantly biased by normalization due to different total amounts of
heavy- and light-amino-acid-labeled mitochondrial proteins (see
Fig. S3B and Text S1 in the supplemental material).
The most significant upregulation within this group was in
proteins only recently identified to play a role in mitoribosome
biogenesis, a process which is still poorly understood. We ob-
served a 6-fold viral induction of mTERF3 (50), a 5-fold induc-
tion of MPV17L2 (51) and a 4-fold increase in NSUN4 (52),
ERAL1 (53, 54) and MRM3 (RNMTTL1) (26, 27). Translation
of mitochondrial proteins, like bacterial proteins, requires an
initiating formylated methionine. The formyl group is supplied
by one-carbon metabolism (55). Consistent with this, we also
observed an upregulation of enzymes that participate in one-
carbon metabolism in the mitochondria, including mitochon-
drial bifunctional methylenetetrahydrofolate dehydrogenase
(MTHFD2 [5.2-fold]), monofunctional C1-tetrahydrofolate
synthase (MTHFD1L [2.2-fold]), and mitochondrial methionyl-
tRNA formyltransferase (MTFMT [2.3-fold]).
Taken together, our SILAC data suggest that regulation of
mitochondrial translation is a key process in viral induction of
mitochondrial biogenesis. This is in line with a previous report
showing that chloramphenicol (which specifically inhibits mi-
tochondrial translation) abrogates HCMV induction of mito-
chondrial respiration (13).
In contrast to the upregulation of mitochondrial genome ex-
pression factors, the vast majority of nucleus-encoded proteins of
the respiratory complexes were not affected by HCMV infection
(see Table S3 in the supplemental material). Exceptions to this
were several proteins suggested to be involved in assembly of the
respiratory complexes, which involves the integration of nuclearly
and mitochondrially encoded proteins (highlighted in green in
Table S3). These proteins included the complex I assembly factors,
evolutionarily conserved signaling intermediate in Toll pathway
(ECSIT), Mimitin (NDUFAF2) and NDUFAF7, and complex III
mitochondrial chaperone BCS1, as well as complex IV cyto-
chrome c oxidase assembly factor 7.
Upregulation of mitochondrial expression factors occurs
early during theHCMV replication cycle. We next used Western
blot (WB) analysis to confirm the changes detected in mitochon-
drial expression factors in our SILAC-MS analysis and obtained a
good correlation of measurements between methods (see Fig. S2C
in the supplemental material). Consistent with our SILAC-MS
data, we observed an upregulation of components of the small and
large mitoribosomal subunits (MRPS 18b, with MRPL12 more
significant for the former), mitochondrial ribosome biogenesis
factors (mTERF3 and MRM3), and mitochondrial transcription
factors (TFAM and TFB2M) in U373 cells at 48 hpi (Fig. 2, left
lanes). ATP5A a nuclearly encoded subunit of respiratory com-
plex V, and the mitochondrial outer membrane protein porin
(VDAC1) were not upregulated by HCMV infection of U373 cells,
consistent with our SILAC data. We also analyzed if this upregu-
lation occurs during HCMV infection of human fibroblasts,
where induction of OXPHOS genes was previously shown (17,
19), and found that upregulation of mitochondrial expression
proteins was more pronounced in HCMV-infected fibroblasts
(Fig. 2, right lanes). In line with our SILAC-MS data, a minor
upregulation of ATP5A and porin was observed in infected fibro-
blasts, consistent with the documented overall increase in mito-
chondrial biogenesis in these cells (13, 17, 19).
We performed a time course analysis to determine the kinetics
of viral induction of mitochondrial expression factors using
MRM3 and TFB2M as representative proteins of the mitochon-
drial translation and transcription machineries. In both U373 and
fibroblast cells, the accumulation of MRM3 and TFB2M was evi-
dent by 24 hpi, and they continued to accumulate through the
viral replication cycle (Fig. 3A). Since upregulation was more ro-
bust in fibroblasts, we continued our analysis in these cells.
mtDNA copy number also increased during HCMV infection at
later stages of the viral replication cycle, in agreement with previ-
ous reports (see Fig. S4 in the supplemental material) (13, 16).
This increase could lead to an induction of mitochondrially en-
coded transcripts (mRNAs and rRNAs). However, an increase in
the levels of mitochondrially encoded mRNAs per se may not be
sufficient (or even required) for increased synthesis of mitochon-
drially encoded proteins as it was recently suggested that mamma-
lian mitochondria (in vivo) contain a great excess of mitochon-
drial transcripts (56). Of note, the 2.7-fold increase in mtDNA
TABLE 1 (Continued)
Protein Gene(s)
H/L ratio
(mock/48 hpi)
No. of unique
peptides Suggested mitochondrial function(s) Reference(s)
Fast kinase domain-containing
protein 5
FASTKD5 0.47 6 Mitochondrial translation (human) 110
Single-stranded DNA-binding
protein, mitochondrial
SSBP1 0.48 8 mtDNA replication 116
Elongation factor G,
mitochondrial
GFM1 0.49 13 Mitochondrial translation (human) 117
Fast kinase domain-containing
protein 2
FASTKD2 0.49 9 Mitochondrial translation (human) 110
Zinc phosphodiesterase ELAC
protein 2
ELAC2 0.49 9 Mitochondrial tRNA maturation
(human)
118
28S ribosomal protein S17,
mitochondrial
MRPS17 0.50 3 Small mitochondrial ribosome
subunit (bovine)
101
HCMV Induces Mitochondrial Translation
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observed at 72 hpi is comparable to the ~3-fold increase in
mtDNA synthesis (as measured by 3H-dT incorporation) at 68 hpi
observed by Furukawa et al. (16) and the 3.5-fold increase in mi-
tochondrial mass (as assessed by nonyl acridine orange staining)
observed by Kaarbø et al. (13). The ~300-fold increase in mtDNA
at 72 hpi reported by Kaarbø et al. (13) was higher than our data
suggest.
Our results suggest that the upregulation of MRM3 and
TFB2M involves early or possibly immediate early (IE) viral gene
expression. Consistent with this, no upregulation of MRM3 and
TFB2M was observed when cells were infected with a UV-
inactivated virus (which failed to produce the viral IE proteins)
(Fig. 3B), and their induction was not perturbed by the viral DNA
polymerase inhibitor phosphonoformic acid (PFA), which blocks
viral late gene expression (marked by HCMV pp28) (Fig. 3B). The
induction of MRM3 and TFB2M was also observed at the level of
mRNA (see Fig. S5 in the supplemental material), supporting the
view that viral regulation of these genes is likely to be transcrip-
tional.
HCMV genes known to target mitochondria are dispensable
for induction of mitochondrial expression factors. Two HCMV
gene products have previously been shown to affect mitochon-
drial respiration: the UL37x1 protein and the long noncoding
2.7 RNA. A UL37x1 knockout virus was partially impaired in
induction of respiration (13), while a2.7 knockout virus failed to
maintain ATP production throughout the viral infection cycle
(25). We therefore determined whether the UL37x1 and 2.7
RNA genes are important for the induction of mitochondrial ex-
pression factors observed at early stage of HCMV replication. We
found that neither UL37x1 nor2.7 is required for viral induction
of MRM3 and TFB2M (Fig. 4). The identity of the viral gene or
genes that govern this induction remains to be determined.
HCMV induces the production of mitochondrially encoded
proteins. Having demonstrated that HCMV upregulates proteins
of the mitochondrial transcription and translation machineries,
we asked whether mitochondrial translation and the end products
of these processes, mitochondrially encoded proteins, are also in-
creased by HCMV infection. We first analyzed the assembly of
mitochondrial ribosomal proteins following infection using su-
crose gradient separation. We found an increase in assembled mi-
toribosomal subunits in the dense fractions using antibodies
against the large (MRPL12) (Fig. 5A) and small (MRPS18b
[Fig. 5A] and MRPS17 [not shown]) ribosomal subunits.
We next looked at steady-state levels of mitochondrially en-
coded proteins and found that mtDNA-encoded cytochrome oxi-
dases 1 and 2 (mt-CO1 and mt-CO2), components of respiratory
complex IV, were both upregulated after 48 h of infection of fi-
broblasts (Fig. 5B; see Fig. S6A in the supplemental material). In
contrast, the levels of nuclearly encoded succinate dehydrogenase
A (SDHA), part of respiratory complex II, were not significantly
changed by infection. Of note, a moderate increase in mt-CO2 was
observed in HCMV-infected U373 cells only at 72 hpi (see
Fig. S6B) and not at 48 hpi (see Fig. S6B and Table S1A and S1B in
the supplemental material). The increased upregulation of mito-
chondrially encoded proteins in infected fibroblasts compared to
U373 cells correlates with the robust upregulation of mitochon-
drial transcription and translation factors in the former, as shown
in Fig. 2.
We then followed mitochondrial translation by radiolabeling
mock-infected and HCMV-infected cells with [35S]methionine in
the presence of emetine, which specifically blocks cytosolic (but
not mitochondrial) translation. When equal amounts of cell ly-
sates were separated by SDS-PAGE and analyzed by autoradiog-
raphy, we found that radiolabeling of mitochondrially encoded
proteins was reduced after 24 h of HCMV infection (Fig. 5C, right
lanes; see Fig. S6C, lanes 1 and 2, in the supplemental material).
This was surprising since our WB analysis (Fig. 5B) suggested an
increase in their steady-state levels. Moreover, we observed a sig-
nificant decrease in the radiolabeling of cellular proteins (when
labeling in the absence of emetine; Fig. 5C, left lanes). Since
HCMV, unlike other viruses, maintains cellular translation and
mTOR activation (57), we questioned if the decrease in radiola-
beled proteins we observed resulted from a specific reduction in
translation or reflected a reduction in [35S]Met uptake by infected
cells under our experimental conditions. We, therefore, measured
trichloroacetic acid (TCA)-precipitable counts ([35S]Met incor-
porated into proteins) and total radioactive count (including all
[35S]Met taken up by the cells) in mock- and HCMV-infected cell
lysates. We found that, indeed, total [35S]Met counts in infected
cells (incorporated and nonincorporated [35S]Met) were reduced
compared to those in mock-infected cells, suggesting that less
[35S]Met was taken up by infected cells. We then calculated cellu-
lar and mitochondrial translation by dividing the TCA-
precipitated counts by total counts, which represents the effi-
ciency of [35S]Met incorporation into proteins and corrects for the
biases in uptake of [35S]Met into the cells. When the above was
taken into account, we found that mitochondrial translation is
specifically induced at 24 h post-HCMV infection, while rates of
cellular translation were similar between infected and uninfected
cells (Fig. 5D). Nonetheless, we cannot exclude the possibility that
HCMV perturbed cellular translation, which was accompanied by
a decrease in uptake of [35S]Met, as translation inhibition was
previously suggested to restrict uptake of at least some amino acids
(58). In this case, our data would suggest a relative increase in
mitochondrial translation over cytosolic translation in infected
cells but not an absolute increase in mitochondrial translation
compared to that in uninfected cells.
Interestingly, when uninfected cells were pretreated for 4 h
with emetine prior to radiolabeling, mitochondrial translation
was essentially blocked, while translation in HCMV-infected cells
was maintained (see Fig. S6C in the supplemental material). It was
previously shown that inhibition of cytosolic translation blocks
mitochondrial translation within several hours, probably due to
an elimination of a short-lived nucleus-encoded mitochondrial
translation factor or factors (59). In sucrose gradients, we have
observed an increase not only in assembled ribosomal subunits
but also in nonassembled MRPL12 (Fig. 5A, fractions 1 to 4).
Having a pool of mitochondrial translation factors (including
nonassembled ribosomal subunits) may allow infected cells to re-
FIG 2 Upregulation of mitochondrial translation and transcription factors in HCMV-infected cells. U373 and human fibroblast (HFFF2) cells were either mock
infected or infected with HCMV (Merlin) at an MOI of 5 for 48 h. WB analysis of total cell extracts using the indicated antibodies is shown. The fold change in
protein abundance measured by WB is presented in the column charts.
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tain mitochondrial translation under stress that blocks cytosolic
translation.
To determine if the stability of mt-CO1 and mt-CO2 was also
affected by viral infection, we blocked mitochondrial translation at
24 hpi using chloramphenicol and monitored the mt-CO1 and mt-
CO2 levels at several time points. We found that the stability of both
mt-CO1 and mt-CO2 was increased by infection (see Fig. S6D in the
supplemental material). Blocking either mitochondrial transcription,
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using ethidium bromide (EtBr) (Fig. 5B), or mitochondrial transla-
tion (see Fig. S6A) immediately after viral inoculation caused, as ex-
pected, an almost complete elimination of mt-CO1 and mt-CO2 but
not of nucleus-encoded SDHA from both infected and uninfected
cells.
This inhibition of mitochondrial transcription and translation
did not feed back to the nucleus to block expression of nucleus-
encoded MRM3 and TFB2M (which are required for these pro-
cesses); viral induction of both proteins was not impaired by EtBr
or chloramphenicol treatments (Fig. 5B; see Fig. S6A in the sup-
plemental material).
Inhibition of mitochondrial ribosome biogenesis interferes
with viral growth. Why might HCMV require an increase in mi-
tochondrial gene expression? Blocking mitochondrial transcrip-
tion or translation after viral infection did not affect the accumu-
lation of immediate early or late viral proteins at 48 hpi, suggesting
that expression of the mitochondrial genome is not required for
viral gene expression (Fig. 5B; see Fig. S6A in the supplemental
material). To evaluate the importance of mitochondrial transla-
tion for viral growth, we blocked mitochondrial translation after
24 h of infection (the earliest time point where we observed an
induction in mitochondrial translation factors) and measured re-
leased virus titers at 120 hpi. Chloramphenicol treatment caused a
statistically significant, yet very minor, ~2-fold reduction in virus
titers when cells were grown on Dulbecco’s modified Eagle’s me-
dium (DMEM) supplemented with glucose (5 mM) (Fig. 6A,
compare the 1st column pair), a similar effect was reported
previously (13). While not leading to cell death (not shown),
this mild effect may result from a slightly poorer health of
chloramphenicol-treated cells. No significant effect on titers was
seen earlier during infection (at 3 days postinfection [dpi]), yet
treatment of cells with chloramphenicol 24 h prior to infection
caused a 0.5-log reduction in viral titers (see Fig. S6E in the
supplemental material). Importantly, we observed a robust1.5
log reduction of viral growth when mitochondrial translation was
blocked under more restrictive conditions. For instance, cell
growth on galactose as a major carbon source is more dependent
on oxidative phosphorylation and is thus routinely used to test
respiratory competence of cells (60). When HCMV-infected cells
were shifted to growth on galactose at 24 hpi, only a minor reduc-
tion in virus titers at 120 hpi was observed compared to growth on
media containing glucose (Fig. 6A, compare black columns 1 and
3). However, a significant 1.5-log reduction in virus titers oc-
curred when chloramphenicol was added to galactose-fed infected
cells (Fig. 6A, compare the 3rd column pair), suggesting an im-
portant role for mitochondrial translation under demanding re-
spiratory conditions. No significant death of infected cells was
associated with growth on galactose either with or without chlor-
amphenicol (data not shown). Impaired growth of cultured cells
treated with chloramphenicol is driven by pyrimidine auxotrophy
due to the requirement of a mitochondrial electron transport
chain for the activity of dihydroorotate dehydrogenase (DHOde-
hase), a key enzyme in pyrimidine biosynthesis (61). Accordingly,
supplementation of chloramphenicol-treated cells with uridine
restores their growth to normal levels (61). Since pyrimidine bio-
synthesis is important for HCMV replication (62), and our
SILAC-MS data show HCMV induction of DHOdehase (see Ta-
ble S1A in the supplemental material), we asked if supplementa-
tion of HCMV-infected cells with uridine would augment viral
growth when mitochondrial translation was inhibited. However,
uridine addition alone could not alleviate the inhibition of viral
production on cells grown on galactose in the presence of chlor-
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amphenicol (Fig. 6A, compare 4th column pair). Thus, the re-
quirement of mitochondrial translation is not due to impairment
of pyrimidine production. This fits our observation that chloram-
phenicol does not prevent late viral protein production (Fig. 5B),
as would be expected if pyrimidine biosynthesis was impaired.
Taken together, our findings suggest that chloramphenicol inhib-
its viral replication due to an energetic deficiency.
Our SILAC-MS data demonstrated that proteins involved in
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mitochondrial ribosome biogenesis are highly induced upon
HCMV infection. On this basis, we asked if depletion of such a
virally induced protein could prevent the induction of mitochon-
drial translation and impair viral growth. Consequently, we trans-
fected fibroblasts with either a control small interfering RNA
(siRNA) or siRNA directed against the virus-induced mitoribo-
somal biogenesis factor MRM3. After 16 h, cells were infected with
HCMV and shifted to galactose medium at 24 hpi. At 120 hpi, we
measured viral titers and analyzed cells by WB analysis. We found
that depletion of MRM3 (~20% relative to control siRNA) abro-
gated viral induction of the mitochondrially encoded CO2 (mt-
CO2). In contrast, nucleus-encoded OXPHOS proteins were not
significantly affected by MRM3 depletion (Fig. 6B). Concomi-
tantly, knockdown of MRM3 significantly reduced viral titers
(Fig. 6C), which mimicked the effect of chloramphenicol
(Fig. 6A). Thus, viral induction of this mitoribosomal assembly
factor appears important for viral growth.
DISCUSSION
HCMV has a profound effect on the expression of mitochondrial
genes as well as on mitochondrial organization and functions.
Here, we have affinity purified mitochondria and used quantita-
tive MS to map the HCMV-mediated changes in the mitochon-
drial proteome. We found that in HCMV-infected U373 cells,
over 20% of mitochondrially associated proteins were signifi-
cantly modulated. We identified several antiviral factors that were
downregulated by HCMV infection, which included proteins in-
volved in regulation of the interferon response, a major target of
HCMV (37). Interestingly, we found that a large group of mito-
chondrial proteins—all involved in mitochondrial gene expres-
sion—were significantly upregulated during infection. This up-
regulation was more robust in infected fibroblasts than in U373
cells, which is consistent with the more efficient viral replication in
fibroblasts (63). The highest fold change occurred in proteins in-
volved in the biogenesis of the mitoribosome. Although, the struc-
ture of the mitoribosome was recently resolved at high resolution
(64), the process of mitoribosome biogenesis is still largely un-
known, and most mitochondrial biogenesis factors we found to be
virally induced have only recently been functionally annotated. It
is tempting to speculate that additional mitochondrial proteins
upregulated by HCMV infection that currently have no annota-
tion might have a role in mitoribosome biogenesis.
HCMV induction of proteins involved in mitochondrial tran-
scription and translation was correlated with an increase in
[35S]methionine incorporation into mitochondrial proteins fol-
lowed by an increase in steady-state levels of mitochondrially en-
coded proteins (Fig. 5). Interestingly, mitochondrially encoded
proteins were induced by HCMV infection at times when gene
expression of nucleus-encoded mitochondrial proteins was un-
changed. Thus, the upregulation in the mitochondrial transcrip-
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FIG 6 Inhibition of mitochondrial translation reduces virus titers. (A)
HFFF2 cells were infected with HCMV at an MOI of 5 for 1 h and then washed
and refreshed with DMEM supplemented with 10% dialyzed FBS, 2 mM glu-
tamine, and antibiotics (DMEM-10dFBS) and 5 mM glucose. At 24 hpi, cells
were washed and refreshed with DMEM-10dFBS containing either 5 mM glu-
cose or 5 mM galactose with or without the addition of 0.2 mM uridine. Each
medium was either left nontreated (nt) or was treated with chloramphenicol
(50 g/ml) to block mitochondrial translation. At 5 dpi, media were collected
from cells, and released virus titers in supernatants were quantified using the
50% tissue culture infective dose (TCID50). Error bars represent the standard
error of the mean (SEM) from two experiments with three replications each.
(B and C) HFFF2 cells were transfected with a control siRNA or an siRNA
targeting MRM3. After 22 h of transfection, cells were infected with HCMV
(Continued)
Figure Legend Continued
(Merlin) at an MOI of 3, and at 24 hpi, cells were washed and refreshed with
DMEM-10dFBS containing 5 mM galactose. At 5 dpi, media were collected
from infected cells, and virus titers were quantified using the TCID50 (C). Cells
were lysed and analyzed by WB; the results of two biological repeats are shown
(B). The chart shows the fold change in protein abundance compared to con-
trol siRNA-treated cells. Error bars in panel C represent the standard errors
from two biological repeats, each performed with three transfection replicates.
*, P 0.05; **, P 0.001 (unpaired t test with Welch’s correction).
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tion and translation apparatuses may prime the biogenesis of the
mitochondrial respiratory complexes. Several lines of biochemical
evidence suggest that the mitochondrially encoded subunits may
form a scaffold during the assembly of respiratory chain com-
plexes that is then joined by nucleus-encoded subunits imported
from the cytosol (65, 66).
Unlike the early induction of mitochondrial genome expres-
sion factors, the increase in mitochondrial DNA copy number
(13) (see Fig. S4 in the supplemental material) and in mitochon-
drial mass (13) occurs only at late stages of HCMV replication. A
similar sequence of events occurs during Arabidopsis germination
(67). In dry plant seeds, mitochondria appear in typical metabol-
ically inert structures, termed promitochondria, and undergo
rapid development and multiplication into mature metabolically
active mitochondria following imbibition (the passive uptake of
water by the seed) (68, 69). A detailed transcriptional analysis
throughout the germination ofArabidopsis thaliana seeds revealed
that transcripts encoding mtRNA transcription, editing and splic-
ing factors peak early during germination. These are closely fol-
lowed by transcripts of mitochondrial OXHPOS genes and by
mitochondrial translation factors. The expression of nuclear
OXHPOS genes lagged behind that of their mitochondrial coun-
terparts (67). It may be that the sequence of events observed dur-
ing the induction of mitochondrial biogenesis in HCMV-infected
cells and in germinating Arabidopsis seeds represents an evolu-
tionarily conserved process. Importantly, while mitochondrial
translation precedes the increase in mitochondrial mass and mi-
tochondrial DNA copy number during HCMV replication, it ap-
pears not to be essential for their induction as neither was blocked
by chloramphenicol (13).
What controls mitochondrial biogenesis during HCMV repli-
cation? Our data strongly suggest that this is a virally driven pro-
cess, as it requires active expression of the viral genome and fails to
occur using a UV-inactivated virus. We show that mitochondrial
expression factors start to accumulate at 24 hpi, suggesting that
viral early genes are involved, although the involvement of IE gene
expression cannot be excluded. However, neither UL37x1, an IE
protein that localizes to mitochondria with early kinetics (21, 22,
70, 71), nor the early 2.7 noncoding RNA (25) (both with doc-
umented effects on mitochondrial function) was required for the
induction of MRM3 and TFB2M (Fig. 4). The identities of the
viral genes that govern this induction remain to be found.
The coordinated induction of mitochondrial transcription and
translation factors is likely to be mediated by a cellular regulator,
possibly activated by a viral gene product. Seo et al. have previ-
ously shown that at 24 h of HCMV infection, viral UL37x1 recruits
the cellular protein viperin to mitochondria, where it interferes
with fatty acid beta oxidation, causing a 50% reduction in cellular
ATP (46). At 72 hpi, however, viperin was relocalized from mito-
chondria to the cytoplasmic viral assembly compartment (46).
This may explain why we have not identified viperin by MS in our
mitochondrial preparations at 48 or 60 hpi. We show that the
induction of mitochondrial expression factors initiates at 24 hpi.
While this induction was independent of UL37x1 (Fig. 4), it re-
mains possible that mitochondrial biogenesis is induced to com-
pensate for an initial perturbation of ATP synthesis which then
allows ATP levels to be maintained later during HCMV infection.
We have previously reported that following an initial (more sub-
tle) reduction in cellular ATP following HCMV infection of U373
cells, ATP levels persist for at least 5 days postinfection (25). A
compensatory increase in mitochondrial biogenesis was reported
for multiple respiratory chain dysfunctions (72–74) and was pro-
posed to explain an increase in mitochondrial mass in certain
types of tumors (75).
Although several master regulators of mitochondrial biogene-
sis have been identified (reviewed in reference 76), to our knowl-
edge, there is no transcription factor yet known to specifically
regulate the genes encoding mitochondrial transcription and
translation proteins. Peroxisome proliferator-activated receptor
gamma coactivator 1-alpha (PGC-1) is a transcriptional coacti-
vator that is induced under physiologic conditions that require
mitochondria to produce heat or ATP (76). Although PGC-1
transcription is also induced during HCMV infection of fibro-
blasts (13), the late kinetics of induction of PGC1 by HCMV
suggests that PGC-1 is not the initiator of induction of mito-
chondrial genome expression we observed during infection. How-
ever, PGC-1 may be involved in the late increase in mitochon-
drial mass. Nuclear respiratory factors 1 and 2 (Nrf1 and 2) are
transcription factors that regulate the expression of nucleus-
encoded respiratory complex subunits and genes involved in
mtDNA transcription and replication, heme biosynthesis, and mi-
tochondrial protein import (76). Nrf2, which also regulates anti-
oxidant genes (77), is induced early during HCMV infection and
protects infected cells from oxidative stress (78). Importantly,
knockdown of Nrf2 does not cause any inhibition of HCMV
growth under nonstressed conditions (78), unlike the reduction
observed upon mitochondrial translation block (13) (Fig. 6).
Nonetheless, involvement of Nrf2 in HCMV induction of mito-
chondrial expression factors cannot formally be excluded. Some
genes involved in mitochondrial biogenesis are known to be reg-
ulated at the level of translation. mTORC inhibitors suppress the
translation of mRNAs encoding components of respiratory com-
plex V (ATP synthase), complex I assembly factors, as well as the
major mitochondrial transcription factor TFAM and several mi-
toribosomal proteins (79). Analysis of total and polysome-
associated mRNAs from HCMV-infected cells suggested that the
translation of several mitoribosomal subunits was induced by the
virus (18). Some OXPHOS and mitoribosomal proteins were
translationally induced in noninfected cells expressing the HCMV
mTORC1 activator UL38, while others, induced by the virus, were
not induced by UL38 alone. Our analysis suggests that, at least for
MRM3 and TFB2M mitochondrial expression factors (see Fig. S5
in the supplemental material), regulation occurs at the level of
transcription.
Our analysis showed that mitochondrial translation is impor-
tant for HCMV replication, especially under conditions requiring
active mitochondrial respiration. Specific inhibition of mitochon-
drial translation by chloramphenicol or by knockdown of the mi-
toribosome biogenesis factor MRM3 caused an ~1.5-log reduc-
tion in virus titers in galactose-fed cells (Fig. 6A). This inhibition
of viral growth by chloramphenicol could not be rescued by the
addition of uridine (Fig. 6A), previously shown to recover cell
growth arrest by chloramphenicol (61). Taken together, these
findings suggest that mitochondrial translation is important to
keep mitochondria bioenergetically active during viral replica-
tion.
How do other viruses affect mitochondrial biogenesis? Rubella
virus infection causes a significant increase in the activity of mito-
chondrial respiratory complexes II and III, as well as an increase in
mitochondrial membrane potential and cellular ATP levels (80,
Karniely et al.
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81). Increases in mitochondrial membrane potential and ATP also
occur during persistent infection with measles virus (82). Similar
to HCMV, these viruses also have protracted life cycles that may
require prolonged maintenance of mitochondrial activity. Of
note, among their many functions, interferons have been shown
to inhibit mitochondrial gene expression (83–86), supporting the
notion that mitochondrial function is supportive of viral replica-
tion. In contrast, many viruses with a short replication cycle inter-
fere with mitochondrial activity (87). This is well demonstrated
for HSV-1 and HSV-2, which unlike HCMV, have a much shorter
replication cycle, that in culture ends with abrupt cytolysis of in-
fected cells. Both HSV-1 infection and HSV-2 infection result in
reduced levels of cellular ATP and mitochondrial membrane po-
tential at late stages of HEp-2 infection (88). Similarly, the HSV-1
US3 protein is known to induce inhibition of mitochondrial res-
piration in HeLa cells (89). Moreover, in contrast to the induction
of mtDNA synthesis by HCMV, HSV-1 encodes a mitochondri-
ally targeted nuclease, UL12.5, which degrades mtDNA early dur-
ing HSV-1 infection (90). Although the importance of mtDNA
elimination for HSV-1 replication is not understood (90), it is
clear that HSV-1 does not require active and proliferating mito-
chondria, apparently quite unlike HCMV. The importance of mi-
tochondrial integrity as a cue for an immune response has recently
become clear. mtDNA can serve as a stress signal both within and
outside the cell. mtDNA released from cells induces inflammation
by activation of polymorphonuclear neutrophils (PMNs) through
CpG-Toll-like receptor 9 (TLR9) interactions (91). Within cells,
mtDNA released from mitochondria during apoptosis is sensed
by the cytosolic cGAS DNA sensor and leads to the induction of
type I interferons (92–94). It will be interesting to determine
whether, in addition to its metabolic and bioenergetic functions,
induction of mitochondrial biogenesis is important for keeping
HCMV-infected cells immunologically silent.
MATERIALS AND METHODS
Cells and viruses. Primary human fetal foreskin fibroblast cells (HFFF2)
and U373 cells were grown in Dulbecco’s modified Eagle’s medium
(DMEM) supplemented with 10% (vol/vol) heat-inactivated fetal bovine
serum (FBS), 100 g/ml penicillin-streptomycin, and 2 mM L-glutamine
at 37°C in 5% CO2. The HCMV strain Merlin (95) was used in all exper-
iments, except if stated otherwise. The Towne-BAC (bacterial artificial
chromosome) UL37x1 mutant HCMV and its parental strain (96) were
a kind gift from E. Mocarski (Emory University School of Medicine, At-
lanta, GA). The Merlin BAC-derived clone was used for the construction
of a 2.7 strain by recombineering (see Text S1 in the supplemental
material). For the SILAC experiment, media collected from HCMV
(Merlin)-infected cells were spun at 13,530 g (average) for 2 h at 4°C to
pellet viruses. Pellets were then resuspended in SILAC Minimum Essen-
tial Medium (lacking lysine and arginine) supplemented with 10%
dialyzed FBS.
Virus infection. Cells seeded 1 day prior to infection were inoculated
with HCMV at a multiplicity of infection (MOI) of 5 for 2 h unless indi-
cated differently and washed once in medium. Where indicated, cells were
incubated with PFA at 300 g/ml, chloramphenicol at 50 or 100 g/ml,
and EtBr at 40 or 80 ng/ml from the time of infection onwards. For infec-
tion of theUL37x1 mutant and its parental strain (where viral titers were
low), we applied a spin infection protocol, in which plated cells were spun
with virus for 30 min at 730 g at room temperature followed by 1 h of
incubation in a humidified CO2 incubator.
SILAC.U373 cells were cultured in SILAC DMEM supplemented with
10% dialyzed FBS (dFBS), 100 g/ml penicillin-streptomycin, and 2 mM
L-glutamine. SILAC medium was supplemented with either “light” (Arg 0,
Lys 0 [Sigma]), “medium” (Arg 6, Lys 4, [Cambridge Isotope Laborato-
ries]), or “heavy” (Arg 10, Lys 8 [Cambridge Isotope Laboratories])
amino acids at 50 mg/liter and L-proline at 280 mg/liter. Incorporation of
“heavy” label was98% for both arginine and lysine-containing peptides.
Cells were propagated for 7 doublings in SILAC medium to enable incor-
poration of the labeled amino acids into cellular proteins. Twenty-four
hours prior to infection, 75-cm2 flasks were seeded with 3.2  106 cells.
Two flasks were established for each SILAC medium (“light,” “medium,”
and “heavy”). Cells were sequentially infected at an MOI of 3 with HCMV
strain Merlin (prepared in SILAC DMEM). Mock-infected cells (“heavy”)
were inoculated with conditioned medium from HFFF2 cultured cells.
Forty-eight-hour (“light”) and 60-h (“medium”) infections were stag-
gered such that all flasks were harvested simultaneously. Infection effi-
ciency was monitored using HCMV IE1 immunostaining.
Mitochondrial isolation. Mitochondria were affinity purified using
superparamagnetic microbeads conjugated to anti-TOM22 antibodies
(Miltenyi Biotec) (see Text S1 in the supplemental material).
Mass spectrometry and data analysis. Mass spectrometric analysis,
database searching, and data processing were performed as described
previously (97). Briefly, for the three-label experiment (Fig. 1; see
Table S1A in the supplemental material), mitochondrial protein ex-
tracts were separated by gel electrophoresis and divided into 24 gel
slices followed by in-gel trypsin digestion. Liquid chromatography-
tandem MS (LC-MS/MS) was performed using a NanoAcquity ultra-
performance liquid chromatograph (uPLC) (Waters, Milford, MA)
coupled to an LTQ-OrbiTrap XL (Thermo Scientific, Tampa, FL).
Peptides were eluted using a gradient rising to 25% MeCN by 70 min
and 45% MeCN by 80 min. MS data were acquired between 300 and
2,000 m/z at 60,000 full width at half-maximum (fwhm). Collision-
induced dissociation (CID) spectra were acquired in the LTQ device
with MS/MS switching operating in a top-6 data-dependent acquisi-
tion (DDA) fashion triggered at 500 counts.
For the two-label biological repeat (see Fig. S2B and Table S1B in the
supplemental material), mitochondrial protein extracts were dialyzed and
trypsinized on a column as described previously (97). Eluted peptides
were fractionated off-line by high-pH reverse-phase high-performance
liquid chromatography (HpRP-HPLC) using a Dionex UltiMate 3000
powered by an ICS-3000 SP pump with an Agilent Zorbax Extend-C18
column (4.6 mm by 250 mm, 5-m particle size). Mobile phases (H2O
plus 0.1% NH4OH or MeCN plus 0.1% NH4OH) were adjusted to
pH 10.5 with the addition of formic acid, and peptides were resolved using
a linear 40-min 0.1% to 40% MeCN gradient over 40 min at a flow rate of
400 l/min and a column temperature of 15°C. Eluting peptides were
collected in 15-s fractions. LC-MS/MS was performed on 42 combined
fractions as described above but with a gradient rising to 45% MeCN by
100 min and MS/MS triggered at 1,000 counts.
Raw data files were processed as previously described (97) using Max-
Quant version 1.3.0.5 (98) and a mergedHomo sapiens/HCMV strain Merlin
UniProt database (downloaded 9/5/14). Gene ontology cellular compart-
ment (GOCC) terms were added using the UniProt database (99).
Pathway analysis. The Database for Annotation, Visualization and
Integrated Discovery (DAVID) was used to determine Gene Ontology
biological processes (GOTERM_BP) and KEGG pathway enrichment
(28). The groups of virus-induced downregulated and upregulated pro-
teins were searched against a background of all proteins quantified within
the relevant experiment.
Analysis of the mitochondrial ribosome profile on density gradi-
ents. Total cell lysates in (50 mM Tris-HCl, 150 mM NaCl, 1% Triton X-100,
supplemented with protease inhibitor cocktail [Roche]) were loaded on a
linear sucrose gradient (2 ml 10 to 30% [wt/vol]) in a mixture of 50 mM
Tris-HCl (pH 7.2), 10 mM Mg(OAc)2, 40 mM NH4Cl, and 25 mM KCl and
centrifuged for 2 h 15 min at 100,000 gmax at 4°C (39,000 rpm [Beckman
Coulter TLS-55 rotor]). Twenty fractions (100 l each) were collected, and
10-l aliquots of the first 17 fractions containing mitoribosomal subunits and
assembled mitoribosomes were analyzed by WB.
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Mitochondrial translation analysis. Mock-infected and HCMV-
infected cells were incubated for 30 min in L-methionine-free DMEM sup-
plemented with 10% dialyzed fetal bovine serum (dFBS) and emetine
(100 g/ml) to block cytosolic translation and 250 Ci/ml [35S]methionine
(EasyTag L-[35S]methionine [PerkinElmer, Waltham, MA]). For total cellu-
lar translation, 25Ci/ml was used without emetine. After labeling, cells were
washed twice with excess phosphate-buffered saline (PBS) before lysis with
cold radioimmunoprecipitation assay (RIPA) buffer supplemented with
complete protease inhibitor cocktail (Sigma-Aldrich). Insoluble material was
removed from the lysate by centrifugation for 10 min at 10,000 g at 4C.
Equal amounts of protein were spotted onto Whatman filter papers in 4
replicates. After drying, two replicates were used to measure the total counts
per minute ([35S]Met incorporated into proteins [35S]Met taken up by the
cells yet not incorporated), while two replicates were TCA precipitated to
measure the acid-insoluble portion ([35S]Met incorporated into proteins
only) by incubation of 20 min in cold 10% TCA, boiling for 15 min in 5%
TCA, and washing in 5% TCA followed by washing in 95% ethanol and
drying. Radioactive counts were measured after addition of Ultima Gold scin-
tillation liquid (PerkinElmer) using a Tri-Carb 1500 liquid scintillation ana-
lyzer (PerkinElmer). Translation was calculated as TCA-precipitated counts/
total counts. For autoradiography analysis, lysates were separated on 4 to 12%
Bis-Tris Plus PAGE, after which the gel was stained with Coomassie brilliant
blue G-250 (to confirm equal loading), dried, exposed to a phosphorimager
screen, and visualized using a FLA5100 scanner (Fujiimager, Tilburg, The
Netherlands).
Analysis of the stability of mitochondrially encoded proteins.
Mock-infected or HCMV-infected cells at 24 hpi were treated with chlor-
amphenicol (50 g/ml) to block mitochondrial translation. Cell extracts
were made after 0, 6, 12, 24, and 30 h of addition of chloramphenicol and
analyzed by WB for mt-CO2, mt-CO1, and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) as a loading control.
Effect of chloramphenicol treatment on viral titers. Cells were in-
fected with HCMV (Merlin) at an MOI of 5 for 1 h, washed once, and
refreshed with DMEM supplemented with 10% dFBS, penicillin/strep-
tomycin, and 2 mM L-glutamine (DMEM-10dFBS) and 5 mM glucose.
At 24 hpi, cells were washed and refreshed with DMEM-10dFBS me-
dium containing either 5 mM glucose or 5 mM galactose (galactose-
DMEM-10dFBS) with or without the addition of 0.2 mM uridine. Each
medium was either left untreated or treated with chloramphenicol
(50 g/ml) to block mitochondrial translation. At 5 dpi, media were
collected from cells and kept at80°C until assayed for determination
of viral titers (see Text S1 in the supplemental material). Cells were
tested for propidium iodide exclusion to determine viability.
siRNA knockdown of MRM3. RNA interference (RNAi) duplexes
(see Text S1 in the supplemental material) were delivered to 105 cells in
12-well culture plates 1 day prior to infection with HCMV using oligo-
fectamine transfection reagent (Life Technologies). Infection was carried
out at an MOI of 3 in penicillin-streptomycin-free DMEM-glucose. After
24 h of infection, cells were shifted to galactose-DMEM-10dFBS. After
5 days of infection, media were collected from cells and spun at 800 g for
10 min at 18°C. Supernatants were kept frozen at80°C until assayed for
viral titers. The experiment included three transfection replicates and two
biological repeats. Of the three replicate wells, one well was harvested for
WB analysis, while the remaining two wells were used to determine cell
viability by trypan blue exclusion using a Countess automated cell counter
(Life Technologies).
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